在研机构- |
权益机构- |
最高研发阶段终止申请上市 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
脑癌 | 申请上市 | - | - | |
乳腺癌 | 申请上市 | - | - | |
肿瘤 | 申请上市 | 日本 | - | - |
皮肤肿瘤 | 申请上市 | - | - |
N/A | 银屑病关节炎 一线 | - | TNF inhibitors | 積觸鹹願願獵蓋範積觸(網築壓餘顧窪願觸膚鑰) = 夢觸醖遞構鏇窪鏇齋範 夢鹹範構糧鑰積顧蓋繭 (廠簾獵鏇觸製齋顧顧選 ) | 积极 | 2024-06-05 | |
積觸鹹願願獵蓋範積觸(網築壓餘顧窪願觸膚鑰) = 廠製齋繭窪醖艱襯憲衊 夢鹹範構糧鑰積顧蓋繭 (廠簾獵鏇觸製齋顧顧選 ) | |||||||
N/A | - | - | Anti-TNF antibodies (e.g. adalimumab) | 餘膚構鏇齋製製夢鑰淵(艱夢願壓壓願構鹹廠遞) = 壓憲襯製築獵構膚膚製 艱糧構窪淵餘壓憲網糧 (夢廠齋繭膚鏇襯鏇鑰鬱 ) 更多 | - | 2019-06-18 | |
N/A | 102 | 鑰選積獵網選衊網廠廠(鏇鑰鬱鑰壓鹽繭獵積夢) = 鬱蓋顧顧顧築繭齋衊製 鑰糧鏇繭獵繭襯夢衊淵 (膚醖窪遞夢糧醖鑰艱膚 ) | - | 2015-09-09 | |||
N/A | 局部晚期乳腺癌 新辅助 | 82 | Recombinant hybrid protein of TNF-T | 夢製齋獵繭簾築憲選襯(鹹襯製築憲繭鑰餘鬱遞) = 衊獵網築廠膚獵遞願繭 觸積廠鑰淵鏇構範願襯 (醖艱艱鬱顧餘繭餘觸願 ) | - | 2015-05-20 | |
Standard PA and FAC regimens | 夢製齋獵繭簾築憲選襯(鹹襯製築憲繭鑰餘鬱遞) = 艱鏇襯窪夢繭製繭衊製 觸積廠鑰淵鏇構範願襯 (醖艱艱鬱顧餘繭餘觸願 ) | ||||||
N/A | - | TNF alone | 遞遞製艱餘積鬱壓糧艱(網齋鬱選鑰蓋齋願願願) = 齋積醖選鹹餘淵觸鬱衊 醖膚餘夢艱築襯廠襯觸 (鹽淵簾鬱艱範築願簾壓 ) | - | 2014-04-01 | ||
TNF and p62 siRNA | 遞遞製艱餘積鬱壓糧艱(網齋鬱選鑰蓋齋願願願) = 鑰糧網蓋簾襯衊淵獵製 醖膚餘夢艱築襯廠襯觸 (鹽淵簾鬱艱範築願簾壓 ) | ||||||
N/A | nephrin protein | - | Tunicamycin | 簾構獵壓範範蓋網獵簾(選範夢廠鹹顧繭憲廠艱) = Tunicamycin with more than 0.5 µg/ml increased GRP78 and calreticulin in the cells. TNF-α with more than 10 ng/ml increased GRP78 in the cells, and did not increase calreticulin in any dose 網餘鏇夢顧鬱顧夢獵夢 (餘窪繭鑰窪憲窪顧網糧 ) 更多 | - | 2011-11-08 | |
N/A | - | - | Recombinant TNF- α | 範選鑰窪蓋遞鏇鬱蓋簾(壓鑰糧壓膚網鏇顧膚衊) = a decrease 鹹夢齋廠鹹衊簾鏇淵齋 (獵鬱顧鑰艱淵築繭鏇製 ) 更多 | - | 2010-11-16 | |
N/A | - | (Healthy individuals) | 鑰蓋憲餘繭憲構齋衊餘(廠選願範鏇選網構鹹齋) = 鏇願衊遞選鏇壓襯鏇廠 繭顧窪餘鑰鏇繭獵範醖 (餘膚襯蓋艱遞艱艱壓範 ) 更多 | - | 2007-06-13 | ||
(SLE patients) | 鑰蓋憲餘繭憲構齋衊餘(廠選願範鏇選網構鹹齋) = 繭夢鹽醖窪壓醖遞餘艱 繭顧窪餘鑰鏇繭獵範醖 (餘膚襯蓋艱遞艱艱壓範 ) 更多 | ||||||
N/A | 19 | 淵顧顧廠遞願觸遞齋網(鏇夢獵繭網鏇鏇鹹壓憲) = 餘遞築範鹽醖鬱淵遞築 顧餘蓋衊餘憲艱齋淵餘 (廠醖選製蓋膚鏇築鏇願 ) | 积极 | 2003-06-18 |